Pharmacometric analyses to characterize the effect of CSL112 on apolipoprotein A‐I and cholesterol efflux capacity in acute myocardial infarction patients

AIMS: To characterize relationships between apolipoprotein A‐I (apoA‐I) exposure and cholesterol efflux capacity (CEC) and covariate effects following CSL112 (apoA‐I [human]) administration in an integrated population including acute myocardial infarction (AMI) patients. METHODS: A pharmacometric an...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Bo, Duffy, Danielle, Tricoci, Pierluigi, Kastrissios, Helen, Pfister, Marc, Wright, Samuel D., Gille, Andreas, Tortorici, Michael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247400/
https://www.ncbi.nlm.nih.gov/pubmed/33217027
http://dx.doi.org/10.1111/bcp.14666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247400/
https://www.ncbi.nlm.nih.gov/pubmed/33217027
http://dx.doi.org/10.1111/bcp.14666

Ejemplares similares